The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease

Table 3 Treatment and placebo composition

Treatment composition
Component	Quantity
Bifidobacterium animalis subsp. lactis BS01	≥ 1 x 10⁹ CFU
Bifidobacterium longum 03	≥ 1 x 10⁹ CFU
Bifidobacterium adolescentis BA02	≥ 1 x 10⁹ CFU
Fructo-oligosaccharides FOS	2500 mg
Maltodextrin	q.s.
Placebo composition
Component	Quantity
Maltodextrin	q.s.

ISSN: 2055-5784